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ABSTRACT 
IN UTERO DETECTION OF FETAL ALCOHOL SYNDROME USING 
ULTRASONOGRAPHY. Chloe Lynne Thio and Richard R. Viscarello. Department of 
Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT. 
A characteristic consequence of alcohol consumption during pregnancy is fetal 
alcohol syndrome (FAS) which is characterized by growth deficiency, intellectual 
impairment, developmental delay, and craniofacial anomalies. The purpose of this study 
is to test the utility of combining the T-ACE questionnaire, which detects 76% of 
alcoholics, with prenatal ultrasonography for detection of FAS in utero. 
We administered the T-ACE questionnaire to a sample of 265 gravid women at three 
different sites. Ultrasonographic measurements of the mid-face and the cavum-thalamic- 
cerebellar axis were performed at three gestational age ranges: 16-19, 24-28, and 32-35 
weeks. 
The overall percentage of women whose fetuses were at risk for developing FAS, T- 
ACE positive women, was 30.1%. There was a tendency for head circumference, inner 
orbital diameter, mid-orbital to mid-upper lip distance, outer orbital to mid-upper lip 
distance, and cerebellar and thalamic measurements to be smaller in “at risk” fetuses at 
16-19 and 24-28 weeks. Head circumference at 16-19 weeks and cerebellar and thalamic 
measurements in the 24-28 week range were statistically significant as compared to the 
control group at p=.()5, p=.003, and p=.03 levels respectively. A four chamber view of 
the heart was visualized in all fetuses. Two fetuses, whose mothers drank large quantities 
of alcohol throughout pregnancy and were noted to have abnormal cephalometry by 
ultrasound at 16 and 24 weeks, were subsequently determined to have characteristics 
consistent with FAS at birth. 
This study suggests that the distinct craniofacial morphometry characterizing FAS 
may be detectable in utero prior to the third trimester using sonography. Since the most 
severe neurological consequences of FAS may occur in the third trimester and since 

alcoholic women who receive intensive counseling can significantly reduce their drinking 
prior to the third trimester, the combination of early prenatal detection and appropriately 
directed counseling may allow for secondary prevention of the deleterious effects of 
alcohol on the developing nervous system. 
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INTRODUCTION 
The teratogenic effects of alcohol have been recognized since Biblical times as 
evidenced by a passage from Judges 13:7: “Behold, thou shall conceive, and bear a son; 
now drink no wine or strong drink.” In 1899, Sullivan first reported a link between 
alcohol and its effects on the fetus when he noted that female drunkards in a Liverpool 
jail had an infant death and stillbirth rate more than double that of their non-alcoholic 
relatives (Streissguth and al 1980). These findings received little attention until 1968 
when Lemoine, a French physician, first documented his observations of the pattern of 
abnormalities seen in children born to alcoholic mothers (Lemoine et al. 1968). He 
studied 120 children born of alcoholic parents and noted growth deficiency, behavioral 
disturbances, and specific patterns of malformation. 
In 1970, Ulleland noted growth deficiencies in ten offspring of alcoholic mothers 
(Ulleland et al. 1970). In eight of these ten children, Jones and Smith (1973) recognized a 
characteristic pattern of craniofacial, limb, and cardiovascular anomalies coining the term 
fetal alcohol syndrome (FAS) (Jones et al. 1973). Their description, which remains 
accurate today, included the following constellation of characteristics. Growth delay was 
seen in length, weight, and head circumference. Craniofacial anomalies were present 
including short palpebral fissures, maxillary hypoplasia, short nose, short philtrum, and 
microcephaly. Development was delayed with deficits in fine and gross motor skills. 
Cardiac anomalies such as atrial septal defect, ventricular septal defect, and patent ductus 
arteriosus were noted; the incidence of these cardiac defects was variable. Later that 
same year, Jones and Smith reported three additional cases with similar malformations 
(Jones and Smith 1973). After ten years of follow-up, eight of these eleven children were 
still alive and all of them exhibited growth deficiencies and retained their craniofacial 
dysmorphology (Streissguth, Clarren, and Jones 1985). Four were of borderline 
intelligence and four were severely intellectually-handicapped. The degree of mental 
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impairment was directly related to the severity of the craniofacial malformations and to 
the extent of growth deficiency. 
Characteristics of alcohol exposure 
Alcohol is a teratogen which is defined as a substance that induces a developmental 
malformation in a fetus. A teratogen can produce consequences at four levels: 1) 
functional teratogenesis 2) growth deficiency 3) malformations and 4) death (Streissguth 
and LaDue 1987). A dose-effect relationship is postulated to exist although the dose 
required to produce a certain effect varies; higher doses are associated with more 
detrimental consequences (Vorhees 1986). Maternal alcoholism increases the rate of 
spontaneous abortion about two-fold (Abel and Sokol 1988). This is consistent with data 
from animal models demonstrating that resorption rates increase if rodents and monkeys 
are fed diets containing ethanol (Abel and Sokol 1988). Stillbirths, on the other hand, do 
not appear to be associated with ethanol intake (Abel and Sokol 1988). Malformations 
secondary to ethanol are noted in the skeletal, neurological, cardiovascular (seen in about 
50% of the affected fetuses), renal, and possibly immunological systems (Burd and 
Martsolf 1989) (see Table I, p. 41). 
Growth deficiency is often a consequence of in utero alcohol exposure. Abel and 
Sokol note that the average weight of 300 neonates with FAS is 2000g as compared to the 
median weight of 3300g in the United States (Abel and Sokol 1988). Of note, is the 
finding that beer drinkers deliver infants who weigh less than those born to women who 
drink other alcoholic beverages (Abel and Sokol 1986). This finding may be a 
consequence of such epidemiologic factors as the socioeconomic status of those who 
drink beer (Abel and Sokol 1986). In addition, length and head circumference 
measurements are also decreased. Postnatally, these children fail to achieve the same 
growth as their unexposed peers. A recent study examining 61 patients diagnosed with 
FAS or fetal alcohol effects (FAE) between five and twelve years ago demonstrates that 
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height and head circumference remain about two standard deviations below the mean, 
although their weights are closer to the average (Streissguth et al. 1991). 
Functional teratogenesis, which includes both behavioral and intellectual dysfunction, 
is the most detrimental effect of alcohol on the surviving fetus. Behavioral disorders are 
noted as early as the neonatal period with affected newborns exhibiting sucking 
difficulties, jitteriness, opisthotonos, hyperacusis, hypertonia, irritability, and occasional 
seizure activity (Burd and Martsolf 1989). Older infants have disturbed sleep-wake 
cycles, poor visual recognition, slow motor development, hearing difficulties, and 
abnormal language development. Comprehension of language is affected less severely 
than is speech production which includes articulation difficulties, echolalia, and 
perseveration (Streissguth and LaDue 1987). These children also tend to score lower on 
the Bailey developmental scale (Abel and Sokol 1986). Behavioral disorders in older 
children include hyperactivity (present in about two-thirds of those with FAS), attentional 
deficits, abnormal eye-hand coordination, and problems with visual perception. As 
adolescence approaches, their poor social judgment and lack of impulse control lead to 
social maladjustment (Streissguth and LaDue 1987). 
If the mother stops drinking during pregnancy, these effects are less pronounced as 
shown by Warren and Bast (1988). They retrospectively studied 103 neonates who did 
not have overt manifestations of FAS and divided them into three groups (Warren and 
Bast 1988). Group I was comprised of infants whose mothers abstained from drinking, 
group II contained infants whose mothers drank on average 12 ounces per week but 
stopped by the second trimester, and group III consisted of mothers who drank 12 ounces 
per week throughout pregnancy. Examinations of the infants at 3 days, 30 days, and 6 
months post partum showed differences in motor performance, reflexive behavior, and 
autonomic control. The infants who were exposed to alcohol throughout pregnancy were 
most affected while the infants whose mothers did not drink were the least affected. As 
with any other teratogen, these effects are not seen in all infants who have been exposed 
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to alcohol and the degree of the effect is variable. The individual factors which determine 
the final outcome, whether genetic, environmental, or a combination of both, are 
currently not well understood. 
Mental retardation, which is another aspect of functional teratogenesis, is common in 
children with FAS who have a mean intelligence quotient (IQ) of 65 with a range from 15 
to 105 (Streissguth and LaDue 1987). In a series of 20 patients with FAS, Streissguth et 
al (1978) note a direct relationship between IQ and severity of the dysmorphogenesis, i.e., 
the more severe the dysmorphogenesis or the greater the amount of growth deficiency, 
the more severe the intellectual impairment (Streissguth, Herman, and Smith 1978). 
The intellectual handicaps which in utero alcohol exposure produces are not mitigated 
with time. A follow-up study of the first 38 patients diagnosed with FAS or FAE, 
performed between the ages of 12 and 40 years, demonstrates a mean verbal IQ of 63 and 
a mean performance IQ of 77 as determined by either the Wechsler Intelligence Scale for 
Children-Revised or the Wechsler Adult Intelligence Scale-Revised (Streissguth and 
LaDue 1987). These patients also exhibit significant delays in their adaptive living skills 
and socialization skills according to the Vineland Adaptive Behavior Scales (VABS). In 
a recent follow-up study of 61 FAS patients, behavioral and social skills as measured by 
VABS continue to be maladaptive (Streissguth et al. 1991). Overall, 62% of patients 
have a “significant” level of maladaptive behavior and 38% have an “intermediate” level. 
These patients perform best on the daily living skills section achieving a mean test level 
of 9 years at a mean chronological age of 17 years. The mean IQ is 66 and only 6% of 
patients are able to attend regular classes. None of the older patients are independent 
with regards to housing or income. These studies demonstrate that the severe intellectual 
and behavioral consequences of FAS are not ameliorated with age. 
Epidemiology 
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FAS is the leading preventable cause of mental retardation. Approximately 60% of 
American women drink alcohol and about 4% are chronic alcoholics (Abel and Sokol 
1988). Evidence suggests that about 5% of all congenital anomalies may be attributable 
to the effects of ethanol. The prevalence of FAS is estimated in the United States to be 
approximately 2.2/1000 live births, although the rates differ dramatically depending upon 
the population studied (Abel and Sokol 1988). Although FAS is seen among women of 
all racial backgrounds, the prevalence tends to be higher in areas where the majority of 
mothers are either black or Indian or are of low socioeconomic status. Among the subset 
of women who abuse alcohol, the prevalence of FAS is 59/1000. The percentage of 
infants with alcohol effects increases with greater amounts of maternal drinking (Hanson, 
Streissguth, and Smith 1978). 
The Cleveland Fetal Alcohol Study attempted to address the issue of who was more 
susceptible to producing a child with FAS (Sokol, Ager, and Martier). In this study, 8331 
consecutive women were screened at the first prenatal visit. Screening interviews 
included the Michigan Alcoholism Screening Test (MAST), recollection of information 
about the daily alcohol intake for a two week period, and also recollection of nutritional 
habits and drug use. At each interval prenatal visit, the women were questioned about 
their daily drinking histories for the antecedent two week period. Within 72 hours of 
birth, the infants were weighed, measured for length of torso, head circumference, 
palpebral fissures, and examined carefully for any possible alcohol related birth defects. 
Twenty-five FAS-positive infants were bom and fifty non-FAS babies, determined by the 
births preceding and succeeding that of the FAS-positive infants, were selected to serve 
as controls. The mothers in the FAS group were older, more likely to be black, and had a 
higher gravidity and parity. The mothers of the FAS children had higher MAST scores, a 
greater number of reported drinking days, greater intake of alcohol per day, and a higher 
proportion of their alcohol intake from beer. Analysis of these factors revealed that about 
two-thirds of the variance could be explained by the following four factors: high 
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proportion of drinking days, positive MAST score, black race, and high parity. Black 
race was found to increase the risk about seven times after adjusting for the other three 
factors suggesting a genetic predisposition. Susceptibility based on genetic variation has 
been shown in mice as different strains have different blood alcohol levels after being fed 
equivalent amounts of ethanol (Abel and Sokol 1986). Thus, it is possible that those of 
the black race are at a greater risk of obtaining higher blood levels and therefore being 
more at risk to produce children with FAS; although, there have not been any studies in 
support of this idea. 
Abel and Sokol (1986) attempted to verify parity as a factor in susceptibility to FAS 
(Abel and Sokol 1986). A group of rats that had mated three times was contrasted to a 
nulliparous group. Rats from the multiparous group were mated a fourth time and those 
from the nulliparous group were mated for the first time. During the mating, they 
received either alcohol, nothing, or a vehicle. The rats born to primiparous females 
weighed about 0.5g more than those born to multiparous females. In addition, they found 
that the pups born to the alcohol fed females weighed less. However, there was no 
interaction between these two variables. Statistical analysis was not done on these 
numbers, so the significance of a 0.5g difference is unclear. 
Placental transport of ethanol 
Despite the high prevalence of FAS, ethical reasons prevent human studies on the 
absorption of alcohol and its variable transfer across the placenta, although one study did 
examine this (Brien et al. 1983). Brien studied six gravid subjects, who entered the 
hospital for a voluntary abortion in the early second trimester, and administered 0.3g/kg 
of ethanol prior to each abortion. The maximum maternal blood ethanol concentration 
varied from 0.23 to 0.73 mg/ml, and the time required to reach this maximum level 
ranged from 15 minutes to one hour. A variable period of 15 to 45 minutes was required 
before ethanol could be measured in the amniotic fluid; after 1.5 to 2.5 hours, the 
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maximal ethanol concentration of 0.09 to 0.31 mg/ml was attained. Acetaldehyde, on the 
other hand, was measurable only in the amniotic fluid of one and in the maternal blood 
of four subjects. After 3.5 hours, ethanol continued to be measurable in amniotic fluid, 
whereas it was not detectable in maternal blood. Thus, this study shows that maternal 
absorption and transfer of ethanol across the placenta is variable as is acetaldehyde 
production. In addition, it suggests that the fetus is exposed to ethanol longer than is the 
mother; thus, even after binge drinking, the fetus is exposed for a longer period of time 
than one would predict from the maternal blood ethanol level. 
Animal studies 
With animals, the amount of alcohol delivered can be controlled; therefore, they have 
been used to evaluate the critical time and pathophysiology of alcohol teratogenesis. 
Alcohol has been shown to produce neurological defects with exposure as late as the third 
trimester (Diaz and Samson 1980). Diaz and Samson (1980) examined the effects of 
alcohol exposure in rats during the immediate postnatal period, which is equivalent to the 
third trimester in humans. Intragastric nasal cannulas were used to feed ethanol-milk 
formula or milk formula alone to rat pups on postnatal days 4-7. On each day, the rats 
were given a battery of tests including “righting”, negative geotaxis to a 30° slope, free 
fall righting, and cliff avoidance. The animals who were fed ethanol appeared sedated 
and had impaired performance on all reflex tests, a finding which persisted for days after 
the ethanol exposure. At postnatal day 17, the control and experimental pups were 
performing equally on the “righting” and cliff avoidance tests, but the experimental group 
continued to have difficulty with the free fall righting and negative geotaxis, which 
require the greatest motor coordination. On postnatal day 40, the rats were sacrificed and 
various measurements of the brain were obtained. The brains of rats from the ethanol-fed 
group weighed 19% less than the control (p<.01) and had statistically smaller cerebellums 
and cerebral hemispheres. Thus, Diaz and Samson concluded that ethanol exposure even 
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late in gestation can effect neurological development including the production of 
microcephaly. 
A mouse model has been used to study the effects of brief alcohol exposure early in 
gestation (Sulik, Johnston, and Webb 1981). Sulik et al. injected C57BL/6J female mice 
with a solution of 25% ethanol (0.015 ml/gm maternal body weight) four hours apart on 
the seventh day of gestation. On day 7, the mouse embryos undergo formation of the 
mesoderm which is responsible for induction and maintenance of the neuroepithelium. 
One week after injection, the mothers were sacrificed and the embryos examined. The 
incidence of embryonic resorption in the experimental group was 18% as compared to 
10% in the control litter. The most readily identifiable malformations in those who were 
given ethanol were microophthalmia, coloboma of the iris, and short palpebral fissures. 
These infants also had abnormal development of the nasal processes, philtrum, and upper 
lip, which are areas derived from the embryonic frontonasal prominence, lateral nasal 
processes, and medial nasal processes. In addition, brain size was reduced in the ethanol 
treated pups. Scanning electron microscopy (SEM) revealed bleb formation, consisting 
of cytoplasmic and nuclear material, on the neuroepithelium. Two embryos were 
exencephalic or anencephalic which is thought to be secondary to the neuroepithelial 
changes seen in some pups. This study demonstrated that exposure to ethanol or its 
metabolites could have a profound effect during a time period equivalent to the third 
week of human gestation. These abnormalities seen in mice were consistent with the 
craniofacial abnormalities seen in humans. In a subsequent study, the time of the initial 
injection was either at 6 days 20 hours, 7 days 0 hours, or 7 days 4 hours (Sulik and 
Johnston 1983). The group which was initially injected at 7 days 0 hours exhibited the 
greatest craniofacial defects, so tissues from this group were examined with SEM. 
Samples obtained 24 hours after the initial exposure revealed a reduction in the size of the 
neural plate, especially in the region of the forebrain, which would be expected to result 
in abnormal brain and eye formation. SEM analysis of embryos later in development 
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revealed that the medial nasal prominences, which contribute to formation of the philtrum 
and portions of the midface, are closer to the midline and are smaller in size as compared 
to the controls. Both of these studies showed alteration in craniofacial development 
following acute alcohol exposure early in gestation, but whether it is alcohol or a 
metabolite or both which caused these anomalies is unknown. 
Webster et al attempted to address the question of the effects of acetaldehyde, a 
metabolite of ethanol (Webster et al. 1983). They injected or fed a group of mice alcohol 
(2.9 g/kg), injected a second group with acetaldehyde (0.32g/kg), or injected a third group 
with a combination of disulfiram (aldehyde dehydrogenase inhibitor) followed later by 
alcohol. The disulfiram was expected to produce a consistently high level of 
acetaldehyde. Two injections were given four hours apart on either days 7, 8, 9, or 10 of 
gestation. The alcohol produced variable defects dependent upon the day it was given 
and the resultant blood alcohol concentration. Alcohol given on day 7 produced 
craniofacial and neural tube defects, whereas, alcohol treatment on day 9 or 10 resulted in 
limb defects. The most common limb defects were reduction of forelimb and absence of 
the fourth or fifth digits. The acetaldehyde-treated groups demonstrated a lower number 
of abnormalities than did the alcohol groups but slightly more than the control group. 
The mice which were given disulfiram also showed a low incidence of malformations. 
This study suggested that acute ingestion of alcohol, or binge drinking, can produce 
malformations in the fetus, but it did not settle the argument about the teratogenicity of 
acetaldehyde since the acetaldehyde-treated groups experienced malformations but did 
not differ significantly from controls. The experiments with disulfiram were not different 
from those in which only alcohol was administered; thus implying that the acetaldehyde 
effect was minimal. However, since the teratogenic effects of disulfiram have not been 
investigated in the mouse, these results could not be interpreted. 
The effects of acetaldehyde have been investigated more thoroughly by O’Shea and 
Kaufman. They injected either a 1% or 2% solution of acetaldehyde into the tail of 
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pregnant female mice and compared their offspring to control offspring from mothers 
who received a saline injection (O'Shea and Kaufman 1979). The number of resorptions 
was higher in the acetaldehyde-treated mice with a 2% injection solution producing the 
greatest effect (p<.05). Embryos who were treated with 2% acetaldehyde also showed 
developmental retardation as they did not adopt the fetal position as readily as controls. 
The crown-rump length was inversely associated with the concentration of acetaldehyde. 
Neurologic anomalies, namely failure of the anterior or posterior neuropore to close, were 
detected in embryos treated with either acetaldehyde or ethanol. Two embryos out of 122 
showed cardiac anomalies. They concluded that acetaldehyde can cause some effects of 
FAS including death (resorptions), neurological abnormalities, growth retardation, and 
developmental delay. In a subsequent study, O’Shea and Kaufman (1981) demonstrated 
that injections given on the sixth day produced defects in the low cervical and high 
thoracic openings while injections on the seventh day produced hindbrain and midbrain 
malformations (O'Shea and Kaufman 1981). Examination of the neuroepithelium by 
scanning electron microscopy revealed an irregular cell surface with cells connected by 
spiny processes. The cells were disorganized with loss of their radial orientation. Some 
cells had small protrusions which may represent processes that were extruded from the 
cells. 
Profound neurological impairment including mental retardation is one of the most 
devastating findings in FAS. The hippocampus, which is thought at least partially to 
contain the faculty of memory, has been implicated as a target for ethanol in the 
developing fetus. West et al. studied the organization of the hippocampus in rat pups 
whose mothers were fed a 35% ethanol diet and he noted a reorganization of the mossy 
fibers (West, Hodges, and Black 1981). Notably, although only one of six rats 
manifested external anomalies, they all still had the altered mossy fiber structure. Wigal 
and Amsel also studied hippocampal structure in four groups of rats: control, prenatal 
alcohol exposure, postnatal alcohol exposure, and combined pre- and post-natal alcohol 
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exposure. (Wigal and Amsel 1990). From postnatal days 19-21 various behavioral tests 
were performed after whieh the animals were sacrificed and the hippocampus examined 
on postnatal day 21. Prenatal alcohol exposure was associated with a decreased 
pyramidal cell density in the CA1 region and a decreased mature granule cell density in 
the dentate gyrus. The density of the CA1 region correlated directly with the rat’s ability 
to learn, i.e. the alcohol-exposed rats with less pyramidal cell density had a more difficult 
time learning to perform a task. Postnatal alcohol exposure resulted in an increased 
density of the CA4 region which is thought to have been secondary to hypertrophy of 
granule cell axons. Thus, the brain appeared to undergo reorganization during the rat 
postnatal period which is equivalent to the third trimester of human gestation. 
A great deal of in vivo animal work has been done, but in vitro studies are scarce. In 
vitro studies are advantageous because one can control the amount of substance in the 
culture medium without concern for effects of metabolic products. In addition, the 
variable absorption in the gastrointestinal system or the variable transfer across the 
placenta is not a factor. Brown et al. (1979) used the post implantation rat embryo culture 
technique to grow rat conceptuses during the period of organogenesis in two different 
concentrations of ethanol and to compare them with a control group grown in culture 
media for 48 hours (Brown, Goulding, and Fabro 1979). Embryos cultured in alcoholic 
media demonstrated a significant dose response reduction in the crown-rump length and 
head length (pc.Ol). The yolk sac and placenta did not differ much in size as compared 
to controls. Also, the higher dose ethanol-treated embryos had a reduced amount of total 
DNA and total protein. This study supported the hypothesis that alcohol alone could 
produce the malformations associated with FAS, but it did not rule out the possibility that 
acetaldehyde also has an effect. 
Campbell and Fantel (1983) studied the effects of alcohol and acetaldehyde using the 
same culture technique for a 25 hour culture period (Campbell and Fantel 1983). The 
acetaldehyde concentrations ranged from 5 to 100 mm which were in the range of 
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physiologic amounts since it has been shown that chronic alcoholic men can attain a 
mean blood acetaldehyde level of approximately 25mm with a range from 5 to 50mm 
(Majchrowicz and Mendelson 1970). The highest concentration was almost uniformly 
lethal with only 1 of 23 embryos surviving. The lowest concentration had no observable 
effect. In a dose-dependent fashion, the intermediate concentrations produced decreases 
in measurements of growth and development. At 75pm, the decrease in total body size 
reached statistical significance. The decrease in head length size reached statistical 
significance at an acetaldehyde concentration of 25pm; thus it appears to be more 
sensitive than total body growth. The ethanol-exposed groups did not have a significant 
reduction in size. As shown in the study mentioned previously, ethanol effects were seen 
after 48 hours in culture, thus, the 25 hour culture period in this study may have been 
insufficient to produce the effects. This study implied that acetaldehyde is also capable of 
producing the teratogenic effects seen in FAS and requires lower concentrations and 
shorter incubation times as compared to alcohol. 
Threshold 
The animal investigations have not determined the threshold at which alcohol 
exposure produces teratogenic effects. Ernhart et al. (1987) attempted to elucidate the 
critical period and threshold for alcohol’s teratogenicity by studying 359 mother-infant 
pairs who were divided on the basis of scores on the MAST questionnaire (refer to 
section of Questionnaires p. 13 for a more detailed explanation of MAST) (Ernhart et al. 
1987). At each succeeding visit, the women were asked to recall their daily alcohol 
intake divided into the categories of beer, wine, and liquor. Only 139 of these women 
registered prior to the end of the first trimester, so for the remainder of the women only 
the amount of alcohol per day during the second trimester was used for analysis. Another 
comparative measurement used was the embryonic alcohol exposure which was 
determined by the following equation: (0.12 * MAST score) + (0.67 current absolute 
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alcohol per day) + .08 (Moron et al. 1985). An anomalies tally, which was was divided 
into craniofacial anomalies and other general anomalies, was used to compare the MAST¬ 
positive and -negative infants. There was a statistically significant increase in the 
incidence of anomalies in the MAST-positive group at pc.001 for the craniofacial and 
pc.05 for the general category. It is important to note that if one looks only at each 
individual anomaly then the difference between the positive and negative groups was not 
obvious, which reinforces the fact that a constellation of anomalies is required for 
diagnosis. In the MAST-positive group, the incidence of craniofacial anomalies was 
significantly related to the absolute amount of alcohol per day and the proportion of 
“drinking days” during the first trimester, but this was not the case for the other 
anomalies. The calculated embryonic exposure accounted for most of the variance 
between the tallies of the MAST-positive and -negative groups; thus, suggesting that the 
critical period is early in the first trimester. They also demonstrated that the 
abnormalities, especially the craniofacial ones are related in a dose response manner with 
>3 ounces of absolute alcohol per day increasing the risk for FAS. 
Questionnaires 
As one can see from the above studies, there is little definitive data on the 
pathophysiology of FAS; therefore, physicians need a reliable method of screening 
expectant mothers for alcoholism. It is difficult to determine the maternal alcohol history 
since many patients are not accurate in their assessment or recall of the amount they 
drink. This factor compounds the problem of a lack of an accurate prenatal diagnostic 
test for FAS, since a physician is not able to determine which patients are at risk for 
bearing children with FAS. Several questionnaires have been devised to determine the 
risk of a patient for alcoholism. The Michigan Alcoholism Screening Test (MAST) was 
devised to provide health care personnel with an unbiased, structured form to detect 
alcoholism. The test consists of 25 questions which are each assigned a point score from 
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0-5; a total score of 5 or greater is considered to be a positive test for alcoholism (Selzer 
1971). Selzer attempted to validate this scoring system in 1971 when he administered the 
questionnaire to five groups of people: controls, hospitalized alcoholics, those convicted 
of drunk driving, those convicted of drunk or disorderly conduct, and drivers with 
licenses under review. The scores on the test were then compared with records of various 
medical and social agencies and criminal records. Using this system, the MAST, which 
had a 5% false positive rate in the controls, was able to detect 59% of the people who had 
been arrested for drunk and disorderly conduct, 55% who had been arrested for drunk 
driving, and 98% of the people who were hospitalized alcoholics. Therefore, this test is 
good for detecting those with serious alcohol problems, i.e., have a need to be 
hospitalized, but it is not as accurate in detecting less severely affected individuals. In the 
gravid population, one needs to detect not only those who are serious alcoholics, but also 
those who one may not suspect since the amount of alcohol which produces an effect on 
the fetus during pregnancy remains to be determined. It is also of interest to validate the 
MAST against simply asking the patient if he or she is an alcoholic. 
The CAGE test, introduced in 1970 by Ewing and Rouse, provides a simpler method 
than the MAST for detection of alcoholics (Ewing 1984). This test is a four question 
script which asks the following: 
1) Have you ever felt you ought to Cut down on your drinking? 
2) Have people Annoyed you by criticizing your drinking? 
3) Have you ever felt bad or Guilty about your drinking? 
4) Have you ever had a drink first thing in the morning to 
steady your nerves or get rid of a hangover (Eye-opener)? 
This questionnaire is much shorter than the MAST and thus can more easily be 
incorporated into clinical practice. Compared to the MAST, the CAGE successfully 
detects 93% of those who drink excessively. Using the CAGE as a model, Sokol devised 
the T-ACE questionnaire, which replaces the question about guilt with one asking how 
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many drinks it takes to make one feel high (Tolerance). A positive response to the 
question of tolerance is defined as >2 drinks. The question of tolerance is thought to 
trigger less denial than the question of guilt (Sokol and al 1989). Sokol studied the utility 
of this questionnaire in a population of 971 gravid women with drinking histories and 
compared results to the MAST and the CAGE. The results show that a positive response 
to the tolerance question seems to increase the likelihood of risk drinking by 8.5% which 
is much higher than the likelihood of increased risk drinking with a positive response to 
any other individual question. In scoring the questionnaire, he assigns the tolerance 
question 2 points and a positive response to any of the other questions 1 point. A T-ACE 
score >2 is considered to be positive and hence to more indicative of a potential to be a 
risk drinker and thus jeopardizing the fetus. In comparison to the CAGE and MAST, the 
T-ACE has a higher sensitivity and specificity. Sensitivity for T-ACE is 76% as 
compared to 59% for MAST. The T-ACE is thus able to predict 7 in 10 women who are 
abusive drinkers (see Table II p. 42). This study only included those who admitted to 
drinking at some point during their life, thus a bias may have been introduced. 
Waterson and Murrary-Lyon compared different methods of asking about alcohol 
consumption in a prenatal clinic (Waterson and Murrary-Lyon 1989). As part of the 
clinical history, the patients were asked quantity-frequency questions, a question on binge 
drinking, and the CAGE questionnaire. Later, they completed a detailed questionnaire 
which included frequency of drinking different types of alcohol, the CAGE questions, 
and the MAST questions. Their results showed that asking quantity-frequency questions 
along with a question on binge drinking was a quick and reliable method of estimating 
alcohol intake. 
Of the questionnaires available to detect alcoholism, the MAST is the gold standard. 
After the MAST, the CAGE is the next most widely used questionnaire for detecting 
alcoholism. The principal advantage of the CAGE is its brevity without loss of 
sensitivity. Recently, the T-ACE questionnaire was introduced which has the advantages 
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of being concise and is superior to both the CAGE and the MAST as demonstrated by its 
higher sensitivity. 
Diagnosis 
Despite the voluminous amount of research and the rapid rate of discovery about FAS 
over the past fifteen years, the diagnosis of FAS remains problematic due to the lack of 
available definitive laboratory or other diagnostic tests. A more precise definition was 
adopted in 1980 by the Fetal Alcohol Study Group of the Research Society on 
Alcoholism in order to make the diagnosis of FAS more uniform. The following are the 
minimal criteria for the diagnosis of FAS with symptoms from each of the following 
areas required for diagnosis (Cooper 1987). If defects are noted in only one or two of 
these categories, then the diagnosis of fetal alcohol effects (FAE) can be made (Cooper 
1987); although, this definition is not strict. 
1) Growth retardation: prenatal and/or postnatal with 
weight, length, and/or head circumference below the 10th 
percentile. 
2) Central nervous system: Signs of developmental delay, 
intellectual impairment, or neurologic abnormality. 
3) Facial dvsmorphologv: Requires two of the following 
three signs: a) microcephaly with head circumference 
below the third percentile; b) microophthalmia or short 
palpebral fissures; and c) poorly developed philtrum, thin 
upper lip, or maxillary hypoplasia. 
Although these criterion attempt to standardize the diagnosis, the clinician must still 
exercise judgement based on the overall appearance and behavior since a common 
unfailing characteristic does not exist. The facial characteristics are the most consistently 
seen defects and include short palpebral fissures, flattened nasal bridge, presence of 
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epicanthal folds, shortened nose, short indistinct philtrum, small chin, thin upper lip, and 
midface hypoplasia (see Figure I p. 48) (Streissguth and LaDue 1987). 
The possibility of prenatal diagnosis based on laboratory tests has been investigated 
by Halmesmaki et al. They studied the utility of a-fetoprotein, human placental lactogen, 
and pregnancy specific B1-glycoprotein as markers for FAS (Halmesmaki et al. 1986). 
a-Fetoprotein was chosen since it is produced by the fetal liver which may be damaged 
by exposure to ethanol and thus unable to synthesize normal amounts. Ethanol could 
damage the placenta, so the other two markers were chosen to assess placental function 
and to screen for significant placental damage. The cohort consisted of 35 women who 
drank throughout pregnancy and 14 women who were abstinent. Thirteen women gave 
birth to infants who were thought to have FAS, one of which was a stillbirth. Low 
a-fetoprotein predicted FAS in 59% of the cases with a sensitivity of 43% and pregnancy 
specific B1 -glycoprotein predicted 56% of the cases with a sensitivity of 60%. Human 
placental lactogen had no predictive value. While this study does not invalidate the use 
of maternal serum markers, their reliability does not justify their use as standard prenatal 
markers. 
In 1984, Vitez et al attempted to apply a more rigorous requirement to making the 
diagnosis of FAS by devising a semiquantitative scoring system (Vitez et al. 1984). They 
studied 464 children born of alcoholic mothers (301 continued to drink throughout 
pregnancy and 163 abstained during pregnancy) and 464 children born of non-alcoholic 
mothers. They examined 60 traits and assigned each trait a score with a more negative 
score being equivalent to slower development. The features encompassed CNS deficits, 
growth parameters, craniofacial defects, and other assorted anomalies. The mean score of 
the 301 children whose mothers imbibed was -14.4 points with most of the scores in the 
range of -30 to +5 points. A number of children in this set scored below -30 points. For 
the group of 163 children whose alcoholic mothers abstained during pregnancy the mean 
score was -4.11 points with the majority falling between -15 and +10 points. The 
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matched control group of 464 children had a mean score of +1.97 with the majority in the 
range from -10 to +15 points. According to their scoring system, a child with a score of 
-30 or less was considered to have FAS, while a child whose score fell between -30 and 
-10 was suggestive of an atypical form of the syndrome (FAE). The group whose 
mothers were abstinent scored slightly lower than the control group although no statistical 
analysis was done. The abstinent group combined mothers who were alcoholics prior to 
pregnancy and abstained during pregnancy with those who did not become alcoholics 
until after pregnancy; thus, it is unclear why the abstinent group would score lower 
especially since two-thirds of the mothers in that group did not become alcoholics until 
after delivery. Further analysis of the subsets of women comprising the abstinent group 
may help to determine whether the difference in scores could be accounted for by 
excessive drinking prior to conception. It is also possible that the difference could be 
accounted for by the inaccuracies of studies which rely on self-reported estimates of 
drinking behavior. 
Craniofacial measurements 
The unique feature of FAS is the craniofacial dysmorphology. The women who 
abuse alcohol often simultaneously use other drugs including marijuana, cocaine, 
tobacco, etc. These other drugs are not associated with the craniofacial features seen in 
FAS. Graham et al (1988) studied the relationship between other drug use and the 
presence of features of FAS in 108 children of heavy drinking mothers as compared to 97 
children of a control group of mothers (Graham et al. 1988). Children were judged on 
FAS characteristics by a dysmorphologist who was blinded to the maternal drinking 
histories. Logistic regression analysis demonstrated no significant association between 
nicotine, caffeine, and marijuana with the presence of facial features of FAS. However, 
alcohol was significantly related to certain facial dysmorphic features even after 
statistically adjusting for the use of other drugs (p=.002). Hanson et al. reported varying 
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maternal nicotine histories in 11 of 163 children diagnosed with FAS by clinical 
examination (Hanson, Streissguth, and Smith 1978). They also demonstrated that in the 
absence of alcohol use, heavy nicotine use was not related to the diagnosis of FAS. 
When the effects of nicotine were studied alone, there was a significant reduction in birth 
weight and length and an increase in perinatal death, but no reduction was found in head 
circumference or in catch up growth and development (Hardy and Mellitis 1972). 
Rostand et al. (1990) recently reported the results of a blinded study to assess the 
significance of the craniofacial anomalies (Rostand et al. 1990). They interviewed 684 
women and divided them into abstinent and light drinkers, moderate drinkers, or heavy 
drinkers based on the number of glasses of alcohol consumed per week prior to 
pregnancy. A morphological exam was performed on the infants with particular attention 
to a set of predetermined craniofacial characteristics. Children of the heavy drinkers had 
a statistically significant greater number of craniofacial characteristics compatible with 
FAS than controls. In addition, there was a trend towards lower birth weight in the 
infants bom to alcoholics although this did not achieve statistical significance. This study 
confirmed the association between the classic facial features and FAS. Other studies 
have determined that the presence of these features at birth is a good predictor of the 
presence of dysmorphic features at 4 years of age (Graham et al. 1988). Graham et al 
compared 108 children born of mothers who were heavy drinkers to children born of a 
matched control group. A different examiner was used at 0 and 4 years of age. At 4 
years, eight out of ten children thought to have fetal alcohol effects at birth were thought 
to have the dysmorphology, however, there was no single feature that was found to be 
diagnostic of fetal alcohol effects. 
Jackson et al. (1990) attempted to better define the craniofacial features associated 
with FAS by studying six selected patients out of 25 who carried the diagnosis (Jackson 
and Hussain 1990). The six were selected based upon a score of -30 or less on the Vitez 
scale, a documented history of maternal alcohol abuse, and absence of endocrine 
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anomalies. The majority of the nineteen children were eliminated because the genetic 
mother was not available to obtain an accurate alcohol history. Only two of these patients 
lived in close enough proximity to the study center to allow for complete craniofacial and 
dental developmental evaluation. The patients underwent standard radiographs and a 
panorex. Both cases had a small head circumference, small head height, shortened 
palpebral fissures, flattened naso-orbital valley, short nose, flattened maxilla and 
zygomas, short upper lip, and small nasolabial angle. There was gross shortage of bone 
in the midface region. They noted that the small palpebral fissures were due to an overall 
reduction in orbital size. There was delay in dental development which paralleled the 
delay in bone development. They noted that many of the fifteen who were excluded from 
the study had the craniofacial features consistent with FAS, but there was no reliable 
evidence of maternal alcohol consumption. The authors concluded that the craniofacial 
features may be more important than previously recognized especially since an alcohol 
history is often difficult to obtain. Despite the limited sample size, these observations 
support the presence of clinically recognizable facial characteristics associated with FAS. 
A more mathematical approach to defining the craniofacial morphology has been 
undertaken by Clarren and coworkers who analyzed photographs of 21 seven year old, 
alcohol-exposed children; two of whom had been previously judged to have FAS (Clarren 
et al. 1987). A control group of 21 children was also photographed. The photographs 
were shown to seven clinicians who were asked to rate the children on a scale of 1-5 with 
1 being indicative of fetal alcohol effects and 5 being normal. Six of the seven clinicians 
were accurately able to determine the children who had been exposed to large amounts of 
alcohol; thus, substantiating the idea that the facies of affected children reflect the high 
levels of alcohol in utero. In the second portion of the study, a group of 23 facial 
landmarks was chosen and their coordinates were fed into a computer and digitized. A 
comparison of shapes of the various facial triangles that could be formed by these points 
was performed and statistical methods were fit to the data to determine if a difference in a 
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triangular shape existed among the groups. Statistically significant differences were 
noted in the measurement of interpupillary distance, midface length with respect to the 
size of the nose, small mandible, and flattened midface. This study is important because 
it shows that the facial changes remain characteristic as these children become older. 
This study also suggests that computer analysis accurately depicts facial features and thus 
may mimic what the clinician’s eye sees. 
Sokol and Chik (1990) computerized the neonatal facial morphometry associated with 
FAS. They took photographs of 97 neonates and entered the coordinates of specific 
landmarks into the computer (Sokol et al. 1990). The characteristic clinical features of 
FAS were statistically significantly associated with the presence of FAS as determined by 
computer analysis with a sensitivity of 75% and a specificity of 79%. Since the 
craniofacial features have been successfully computerized in children and in neonates, the 
next logical step is to perform analysis of the facial features of the developing fetus. The 
ultrasound machine provides similar information to a computer-based analysis, thus 
suggesting the possibility for a role of ultrasonography in the in utero diagnosis of FAS. 
Escobar et al. have shown that accurate, highly reproducible craniofacial measurements 
can be made as early as 16 weeks of gestation (Escobar et al. 1988); thus supporting the 
possibility of prenatal detection of FAS. 
The literature suggests that there are characteristic craniofacial changes in FAS 
apparent in both animal and human models. Further, these changes can be detected 
during development in animal models and are conducive to digitization by computer 
analysis in human neonates and 7 year old children; thus, these changes appear to be 
consistent. Ultrasonography provides physicians a tool to study human development and 
has already proven useful in the prenatal detection of abnormal growth and of abnormal 
organ development. Ultrasonography can detect craniofacial features accurately at 16 
weeks of gestation. In order to detect mothers who put their fetus’ at risk for FAS, a 
highly sensitive questionnaire known by the acronym T-ACE has been developed. 
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Prenatal detection of FAS may allow for the mitigation of the severe neurological 
impairment seen in FAS, which is the most detrimental consequence of in utero alcohol 
exposure. As previously mentioned, animal studies show that exposure to alcohol leads 
to difficulty in motor coordination and to rearrangement of the hippocampal structure. 
Since human studies show that mothers who stop drinking during pregnancy produce 
children with fewer neurological deficits, the possibility of prenatal detection becomes 
more appealing. In order to investigate the feasibility of prenatal detection of FAS, we 
utilized the combination of the T-ACE questionnaire, which detects potential pregnant 
alcoholics, with ultrasonography, which accurately determines craniofacial and 
intracranial measurements during development. 
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METHODS AND MATERIALS 
The idea for this study is the result of discussions among Drs. Sterling Clarren, 
Robert Sokol, and John Hobbins with Dr. Richard Viscarello becoming involved in the 
discussions later. My advisor. Dr. Richard Viscarello, and I completed the design of the 
clinical study and the questionnaire (see Appendix I, p. 50). I completed the pilot study 
to assess the feasibility of the design and the completeness of the questionnaire. During 
the study, the questionnaires were administered either by myself or by a trained 
interviewer. The ultrasonography was performed by trained ultrasonographers or by 
Richard Viscarello, M.D.. Ultrasonographic measurements determined from the pictures 
taken during the ultrasound were determined by myself with the assistance of Richard 
Viscarello, M.D.. I performed the data analysis including writing a computer program to 
divide the data into their appropriate categories and performing the statistical analysis. 
The results published here are from data analyzed at the first data analysis point. In 
order for statistical significance, power analysis calculations assuming a prevalence of 
20% and a confidence of 80% would require 2,620 patients. 
Patient selection 
From 1988-1990, the T-ACE questionnaire was administered by trained interviewers 
to women registering for prenatal ultrasounds at one of three sites: 1) Womens’ Center at 
Yale-New Haven Hospital 2) Perinatal ultrasound unit at Yale-New Haven Hospital or 
3) Gessler Clinic in Winter Haven, Florida. Those women with T-ACE scores >2 points 
(T-ACE positive) were considered to be the “at risk” group and the remainder comprised 
the control group (T-ACE negative). Information regarding tobacco and illicit drug use 
and other demographic information was obtained during the interview (see Appendix I 
for sample questionnaire, p. 50). Oral consent was obtained for participation as approved 
by the Human Investigations Committee of Yale University School of Medicine and all 
patients were protected by a Certificate of Confidentiality obtained from NIAAD. 
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Gestational age was determined by the reported date of last menstrual period and 
confirmed by early ultrasound. Women who were unsure of their last menstrual period 
were excluded from the study as were women with multiple pregnancies. Women who 
were known diabetics were also excluded due to their propensity for fetal macrosomia. 
Ultrasound examinations 
Three time periods were selected for interval ultrasonographic measurements. 
16-19 weeks (Group I): This period, which is equivalent to early second trimester, 
was selected as it is the earliest time in which accurate and complete craniofacial 
measurements can be obtained in the fetus (Escobar et al. 1988). Although vaginal 
ultrasound allows visualization of the face at 10 weeks, all the facial features are not 
distinct and studies have not been performed to assess the accuracy of these facial 
measurements. 
24-28 weeks (Group II): This period, which is the end of the second trimester, allows 
possible detection of anomalies prior to the third trimester in which rapid neurological 
development occurs. 
32-35 weeks (Group III): This interval ultrasound is during the mid third trimester 
allowing for possible detection prior to birth and thus, allowing for appropriate neonatal 
care. 
Trained ultrasonographers performed comprehensive ultrasound examinations on 
each patient at each of the above intervals. All ultrasonographers were blinded to the 
results of the T-ACE screening. At each examination attempts were made to visualize a 
four chamber view of the heart. For various reasons, primarily missed appointments and 
late initial registration, some women did not receive all three ultrasounds. All ultrasound 
examinations were performed on either an ADR/ATL, Ultramark IX, and ADR/ATL 
Ultramark IVa, an Aloka Model 650, or an Accuson 128 scanner. 
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Craniofacial measurements 
The craniofacial measurements studied were chosen to reflect abnormalities seen in 
children with FAS including microcephaly, hypertelorism, and mid-facial hypoplasia. 
These measurements included biparietal diameter (BPD), occipito-frontal diameter 
(OFD), outer-orbital distance (OOD), inner-orbital distance (IOD), mid-orbital to mid¬ 
upper lip distance (MOMUD), mid-orbital to mandible distance (MOMD), and outer 
orbital to mid-upper lip distance (MFT) (see Figure II, p. 49). Head circumference was 
calculated from BPD and OFD using the formula for an ellipse: (Ott 1984) 
VBPD^+ OFD2 *n 
2 
In order to determine BPD and OFD an axial section was obtained. A coronal section 
was taken to determine the facial measurements. 
Intracranial measurements 
The intracranial measurements studied attempted to measure brain size in various 
dimensions as the children with FAS have mental retardation, microcephaly, and 
difficulty with fine and gross motor function. In animals and in autopsy specimens it has 
been shown that the brain has a reduced size during development. The measurements 
studied included transcerebellar diameter (TCD), the distance from the cavum septum 
pellucidum to the inner-table of the skull (C-IS), and the distance from the thalamus to 
the inner-table of the skull (T-IS) (see Figure 2, p. 49). Axial sections at the level of the 
cerebellum and at the level of the thalamus were used to assess these measurements. 
Table III (see p. 43) illustrates which FAS characteristics are being targeted with 
these ultrasonographic measurements and which characteristics cannot be determined by 
ultrasonographic analysis. 
Statistical analysis 
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Statistical analysis between T-ACE positive and negative groups was completed with 
the Mann-Whitney U test. Analysis comparing T-ACE positive to published means was 
done with hypothesis testing and the student’s t-test. In order to determine the means of 
the published standards, the standards for the weeks in each of the groups were averaged. 
The level of statistical significance was chosen as p< .05. 
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RESULTS 
We interviewed a total of 265 gravid women ranging in age from 16 to 43 years 
with a mean age of 26 ± 5.5 years. The mean gravidity was 3.0 ±1.9 with a range from 0 
to 13. Parity ranged from 0 to 7 with a mean of 1.2 ±1.2. The racial make up was 70.7% 
Caucasian, 21.4% Black, 7.3% Hispanic, and 0.6% Other. Overall, 30.1% of the women 
were T-ACE positive; thus constituting a risk of FAS to the fetus. In the Gessler Clinic 
and the Yale Ultrasound Unit, the majority of the patients were Caucasian. During the 
first few months of the study, the Gessler study site matched each T-ACE positive subject 
with a T-ACE negative subject; therefore, the percentage of T-ACE positive patients 
may be falsely elevated and we expect the percentage to decrease at the next data analysis 
point. In the Women’s Center, the majority of patients were black and a large percentage 
of the patients are T-ACE positive. The data for each site is presented in Table IV (see p. 
44). 
Confounding variables which were studied include smoking history and illicit drug 
history as obtained from charts and from questioning. Of the T-ACE positive women, 
almost 63% were cigarette smokers and 56% admitted to illicit drug use. Nearly 9% of 
the “at risk” women were using alcohol, tobacco, and illicit drugs during their pregnancy. 
In contrast, 28% of T-ACE negative women were positive for tobacco use and 6% 
acknowledged the use of illicit drugs. Approximately 2.2% of T-ACE negative women 
were exposing their fetuses to a combination of ethanol, tobacco, and illicit drugs. 
Craniofacial measurements (Data summary in Tables V, VI, VII, p. 45,46, 47) 
Although 265 patients were interviewed, the number of ultrasounds is substantially 
less for several reasons. First, some women did not receive all three ultrasounds. 
Second, women missed appointments and either did not receive ultrasounds or the period 
of gestation in which the ultrasounds were performed did not coincide with the periods 
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we were studying. Third, at the time of analysis, some women had been interviewed but 
had not yet received any ultrasounds. 
Group I: 16-19 weeks gestation 
Group I consists of 51 patients with a mean gestational age of 17.7 weeks for T-ACE 
positive and 17.9 weeks for T-ACE negative women. As displayed in Table V, there is a 
trend for measurements of head circumference, inner-orbital diameter, mid-orbital to mid¬ 
upper lip distance, and outer-orbital to mid-upper lip distance to be smaller in those 
fetuses who are “at risk.” However, only head circumference is statistically significant 
with p=0.05. 
From the measurements we examined, published standards exist only for head 
circumference, inner orbital diameter, and outer orbital diameter (Mayden et al. 1982), 
(Hadlock et al. 1983). There was no statistically significant difference between the 
T-ACE positive women and the standards. 
Group II: 24-28 weeks gestation 
There are 57 patients in Group II. As in the T-ACE positive fetuses in Group I, the 
same measurements are found to be smaller in this group with the addition of mid-orbital 
to mandible distance. Although these differences are not statistically significant, head 
circumference is close with p=0.07. 
Compared to the published means, head circumference and inner orbital diameter are 
statistically significant with p<.01 and p<.05 respectively. The difference in outer orbital 
diameter is not significant. 
Group III: 32-35 weeks of gestation 
Unlike the other two groups, the 25 patients in Group III have measurements in the 
“at risk” (T-ACE positive) group which were often larger than in the control group. But, 
mid-orbital to mandible distance, mid-orbital to upper lip distance, and outer-orbital to 
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mid-upper lip distance remain smaller in those “at risk,” although they are not statistically 
significant. There is no significant difference between published means and T-ACE 
positive fetuses. 
Intracranial measurements (Data summary displayed in Tables V, VI, VII, p. 45, 46, 47) 
Group I: 16-19 weeks gestation 
All three intracranial measurements studied are approximately equivalent in the 
T-ACE positive as compared to T-ACE negative at this age of gestation. 
Of these parameters, only transcerebellar diameter has a published mean, and the 
T-ACE positive women did not differ significantly from it. 
Group II: 24-28 weeks gestation 
In Group II, all three intracranial measurements studied, i.e. transcerebellar diameter, 
thalamus to inner-table of skull, and cavum to inner-table of skull are smaller in the 
T-ACE positive fetuses. The transcerebellar diameter and the thalamus to inner-table of 
skull are statistically significant with p values of 0.003 and 0.03 respectively. 
The transcerebellar diameter as compared to the population mean is statistically 
significantly smaller in the T-ACE positive with p<.01. 
Group III: 32-35 weeks gestation 
In Group III, the intracranial measurements are similar between those fetuses “at risk” 
and the controls except for the TCD in which the controls were larger although not 
statistically significant. The difference between the T-ACE positive and the population 
means for TCD is statistically significant though. 
Other examinations 
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Each patient had a four chamber view of the heart visualized at one of the three 
ultrasound examinations; there were no cardiac defects seen in any patient. In addition, 
there were no skeletal or other organ anomalies seen. 
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DISCUSSION 
The mechanism by which alcohol acts as a teratogen remains unknown, although 
several hypotheses have been proposed. It is suggested that alcohol can cause a reduction 
in amino acid and nutrient transport across the placenta, thus inhibiting fetal growth 
(Fisher and Karl 1988). This diminished transport can be secondary to ethanol’s effects 
on the Na+-K+ ATPase which is shown to be impaired by as little as 60 mg/dl of alcohol 
(Fisher and Karl 1988). Ethanol is shown to impair the transport of such important 
nutrients as zinc, thiamine, and folate, which are required by the fetus for normal growth 
and development. Zinc is necessary for DNA synthesis. Interestingly, zinc is transported 
as a ligand with histidine; thus, zinc deficiency also may be due to decreased amino acid 
transport. Diminished placental transport is not the only mechanism since ethanol can 
also have a direct toxic effect on embryonic growth (Brown, Goulding, and Fabro 1979). 
Fetal hypoxia also is proposed as a hypothesis (Hoyseth and Jones 1989). Since the 
liver requires as much as a one hundred percent increase in oxygen consumption during 
ethanol metabolism, oxygen deprivation in other tissues of the developing fetus can 
result. In addition, large doses of alcohol are shown in monkey to lead to a transient 
collapse of the umbilical vasculature, contributing to fetal hypoxia (Hoyseth and Jones 
1989). 
Increased levels of prostaglandins have also been proposed as a mechanism of 
teratogenesis in alcohol exposed fetuses since alcohol is shown to result in an increased 
level of prostaglandins secondary to stimulation of its release from tissues (Hoyseth and 
Jones 1989). High concentrations of prostaglandins result in increased levels of cAMP 
which decreases the rate of cell division. 
A third possible mechanism of teratogenesis involves an alteration of hormone levels 
due to alcohol consumption (Hoyseth and Jones 1989). Women who give birth to infants 
with FAS are shown to have lower levels of estradiol and estriol throughout pregnancy. 
These women are also noted to have lower levels of progesterone and higher levels of 
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prolactin between the 16th and 24th weeks of gestation. The active mechanism by which 
these hormones may lead to FAS is not yet determined. 
Since the mechanism of alcohol teratogenesis is not known, a safe level of alcohol 
consumption during pregnancy remains to be established making the early identification 
of problem drinking and its therapy essential components of prenatal care. The severity 
of the mother’s alcoholism is shown to be the best predictor of the child’s long term 
outcome (Burd and Martsolf 1989); thus, children of women who drink throughout 
pregnancy are at a higher risk for adverse alcohol related effects. This idea is supported 
by the follow up study of the first eleven FAS children which suggests that the three 
mothers who died of alcohol related causes were the ones whose children were the most 
severely affected (Streissguth, Clarren, and Jones 1985). Another study shows that 
women who discontinue drinking in the first trimester produce infants of normal length, 
weight, and head circumference as well as appropriate growth and development at an 18 
month follow-up period (Burd and Martsolf 1989). Cognitively, children whose mothers 
stop drinking in the first trimester develop normally, but those whose mothers stop in 
mid-pregnancy are one to two standard deviations below the mean. The mothers who 
drink throughout pregnancy bear children whose cognitive development scores fall 2 to 4 
standard deviations below the mean (Burd and Martsolf 1989). 
Although reducing drinking early in pregnancy reduces alcohol related defects, it is 
not known with certainty in which trimester the most severe neurological damage is 
produced. In humans, it is known that from mid-gestation through the third postnatal 
year is the time of most rapid brain growth (Diaz and Samson 1980). Some animal 
studies point to the third trimester as being the most critical stage of neurological 
development. In rats, the first seven to ten days postnatally is equivalent to the third 
trimester in humans (Dobbing and Sands 1979). Rat pups fed an ethanol-milk mixture on 
postnatal days 4-7 demonstrate normal body growth whereas the brain growth especially 
cerebellar growth is significantly lower in the ethanol exposed rats (Diaz and Samson 
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1980). This result is interesting for two reasons. First, some FAS children have minimal 
or no physical FAS features, but they still have the neurological deficits. Secondly, 
children with FAS are noted to have defects in fine and gross motor function which is 
controlled by the cerebellum. 
The hippocampus has been the most suitable region of the brain to study in detail 
because of its precise laminar organization and because the most is known about its 
pattern of development (West, Hodges, and Black 1981). In addition, the hippocampus is 
thought to play a role in learning and memory which is affected in FAS. Rat embryos 
exposed to alcohol during days 10-21 of gestation, the second trimester of human 
development, show a decrease in the dorsal hippocampus pyramidal neurons at 60 days of 
age (Barnes and Walker 1981). In addition, their study found that cerebellar development 
is slowed but not permanently altered by second trimester prenatal ethanol exposure. 
West et al. executed a study in which three groups of rats were exposed to alcohol during 
periods equivalent to the three trimesters in human development (West and Hamre 1985). 
For third trimester exposure, gastrostomy tubes were implanted on the first postnatal day 
and left in until the tenth postnatal day. This study failed to find any alterations in 
hippocampal development in rats exposed prenatally to ethanol. Those exposed 
postnatally showed aberrant production of pyramidal cells in the CA3 region and 
reduction of the cerebellar Purkinje cells. This study, unlike the study by Barnes, failed 
to demonstrate first or second trimester prenatal effects. One reason for this discrepancy 
is that the pregnant rats in Barnes’ study consumed on average 15.5 ± 0.9 g/kg/day of 
ethanol whereas in Wests’ study they consumed 10.8 ± 0.8 g/kg/day. The rats fed 
postnatally received between 7.0 and 7.5 g/kg/day; thus this suggests that the amount of 
ethanol needed to produce a harmful effect during the third trimester is less than during 
the preceding trimesters. Also, some of the effects produced during the second trimester 
can be compensated for if drinking is reduced during the last trimester. 
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The issue of absolute quantity of alcohol ingested versus maximal blood alcohol 
levels is addressed by Warren et al. (1988) using postnatal rat pups divided into two 
groups (Warren and Bast 1988). One group received 12 doses of alcohol daily whereas 
the other group received four doses, but the total amount administered to the two groups 
was equivalent. The animals with the fewer doses, which means they achieved the 
highest blood alcohol level, had the smaller brains for body size as compared to both the 
controls and the animals receiving 12 doses of alcohol. Thus, the idea that the third 
trimester can produce long lasting CNS injury is supported since the rats were fed during 
the period equivalent to the third trimester in humans. These results suggest that a higher 
peak dose may be more important than the total quantity ingested. Although some 
neurological damage is most likely produced in the first two trimesters, these studies 
strengthen the idea that the third trimester is an important and possibly the most sensitive 
time for the effects of ethanol on the developing nervous system. Therefore, detection of 
possible alcohol effects prior to the third trimester has the potential to reduce the severity 
of the mental deficits characteristic of FAS. 
The preliminary results from our study indicate that craniofacial changes 
characteristic of those found in FAS may be detectable as early as 16 weeks in litero with 
most characteristics being more prominent by 24-28 weeks. Although the tendency is for 
most of the craniofacial measurements to be smaller in the “at risk” fetuses only the 
difference in head circumference reaches statistical significance by 16 weeks of gestation. 
At 16 weeks, the differences between the T-ACE positive and the standard means was not 
statistically significant. This could either be because it is not statistically significant and 
just appears so due to the small sample size or because the small T-ACE positive group is 
not large enough for statistical significance. As compared to the published means, the 
inner orbital diameter and head circumference are also statistically significant at 24-28 
weeks. The small sample size could account for a greater statistical significance when 
comparing the T-ACE positive group to the standards as opposed to comparing them to 
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the T-ACE negative group. Throughout all three gestational ages, the outer orbital 
distance is approximately equal in the T-ACE positive and negative groups. Both hyper- 
and hypotelorism have been suggested to occur in FAS (Gir, Aksharanugraha, and Harris 
1989), thus these results may represent a combination of both occurring in the “at risk” 
population. The data must be cautiously interpreted because of the interaction of nicotine 
and illicit drugs with the effects of alcohol especially since drug and alcohol use often 
occur simultaneously. These other drugs can effect parameters such as growth, but thus 
far, only alcohol has been shown to produce the aforementioned craniofacial and 
intracranial features (Ernhart et al. 1987). A study on the effects of nicotine on the fetus 
compared 88 children born to mothers who smoke with 88 controls. Infants exposed to 
nicotine in utero have decreased length and body weight at birth which is compensated 
for with time. A seven year follow up shows no difference between the two groups in 
intelligence. This is unlike FAS where the characteristics do not approach the mean with 
time (Hardy and Mellitis 1972) (Streissguth et al. 1991). With a larger sample size, it will 
be possible to perform multivariate analysis on our data to account for any effects which 
may be secondary to tobacco or illicit drug use. 
The results of the early intracranial measurements are not yet conclusive, but the trend 
is toward smaller measurements at 16-19 weeks in the T-ACE positive women. The 
difference is definitely detectable by 24 weeks with transcerebellar and thalamus to inner 
skull distance being statistically significant. With the required sample size of 
approximately 2600, the abnormalities may be detectable earlier than 24 weeks. 
Comparison of the T-ACE positive data to published population standards indicates 
statistically significant differences in transcerebellar diameter, head circumference, and 
inner orbital diameter in the 24-28 week range. This is consistent with comparison of 
T-ACE positive and negative women. At this data analysis point though, there are not 
enough subjects to confidently use the T-ACE negative group as the control. The 
published standards are a good baseline since they are determined from large studies. 
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Also, these standards are relied upon in obstetric patients as the expected means. Thus, in 
order to substantiate our T-ACE negative population as an accurate control group, it is 
important that the results which are statistically significant between the T-ACE positive 
and T-ACE negative group are also statistically significant between the T-ACE positive 
group and the population means. After this substantiation, we reliably will be able to use 
our T-ACE negative group as a control for the parameters where population means have 
not been determined and for future studies. It is encouraging that this study shows 
differences at 24-28 weeks since rat studies support the idea that detecting intracranial 
changes as late as 24-28 weeks may be adequate to prevent or at least to minimize serious 
mental impairment as significant neurological development occurs in the third trimester. 
The data from third trimester ultrasounds does not show a significant difference 
between the T-ACE positive and negative groups. At present, the reason for this is 
unclear. It is more difficult to perform accurate facial measurements during the third 
trimester as the head engages. Another possibility, and probably the most likely one, may 
simply be an inadequate number of data points. Lastly, it is possible that some of the 
women may have reduced or stopped their drinking by the third trimester, so some of the 
craniofacial and intracranial effects that were measured at 24-28 weeks may have been 
mitigated. In the future, it will be important also to question the women on their drinking 
habits during the third trimester to control for these effects. 
An accurate diagnosis of FAS cannot be made until the neurological development is 
assessed in the early childhood years. In addition, some children have FAE in which they 
may not have craniofacial changes but may have impaired neurological development 
which also will be detected in the early years of life. Therefore, it will not be known with 
certainty which infants are effected with FAS until a follow-up study is performed at 
regular intervals over the next few years in order to look at the social, emotional, and 
intellectual development of the children. Thus far, it appears that 2 of the T-ACE positive 
fetuses may have FAS, but others may later prove to have FAE. This gives us a 
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prevalence of FAS of 1 in 130 in our study which falls within the range seen in the 
population in the United States. 
Even if fetuses at risk can be detected consistently with the combined use of the 
T-ACE questionnaire and ultrasonography, the physician must deal with the issue of 
altering the mother’s drinking. Several studies have documented that supportive 
counseling can be beneficial in "at-risk" women. Halmesmaki has shown that it is 
possible for alcoholic women to reduce their alcohol intake (Halmesmaki 1988). He 
studied 85 pregnant women who abused alcohol and divided them into groups of either 
alcoholics, heavy drinkers, or moderate drinkers. The patients were counselled at 2-4 
week intervals about the effects of alcohol on the fetus. The patients were urged to 
abstain from alcohol, but if they were unable to do so, then they were encouraged to at 
least decrease their alcohol consumption. The patients also had free access to social 
workers and psychiatrists. In addition, they could phone for counseling or simply to talk 
with someone whenever they felt the need. When patients did not come to their follow¬ 
up appointments, they were telephoned and persuaded to come. At each visit, an 
ultrasound examination and urine for alcohol levels were obtained. Overall, the results 
showed that 65% of the women lowered their alcohol consumption by 50%. Of the 36 
gravid women who registered between 12 and 20 weeks, 94% reduced their drinking by 
at least half, as compared with only 54% of women who registered later. Those who 
received counselling after 32 weeks were unable to decrease their alcohol consumption. 
FAS was noted in 20 patients, while FAE was suspected in an additional 22 patients. 
Eighty-nine percent of the infants whose mothers were unable to lower their alcohol 
consumption were bom with FAS or FAE, but only 40% of those whose mothers reduced 
drinking had features of FAS or FAE. Therefore counseling of alcoholic women may be 
efficacious if initiated early in pregnancy. However, the patients in this study who 
registered earlier may have been more motivated to abstain from alcohol during 
pregnancy. 
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Others have also documented success with intensive counselling for pregnant 
alcoholic women. Rosett et al. found that with counseling 67% of heavy drinking women 
were able to abstain or significantly reduce their alcohol consumption prior to the third 
trimester (Rosett, Weiner, and Edelin 1983) (Rosett, Weiner, and Edelin 1981). In 
addition, those who reduced their consumption delivered babies with more normal growth 
parameters. Their program consisted of an initial intake interview and detailed drinking 
history with a psychiatrist followed by a session with the psychiatrist and/or counselor 
occurring one to four times per month. If a woman reported drinking, the harmful effects 
of alcohol were reinforced. In counseling these patients, the researchers found that it was 
important to avoid criticism and feelings of guilt. 
Larsson studied all women who attended one of the four Maternal Health Clinics in 
Sweden (Larsson 1983). The patients were divided into three groups based on the 
amount of alcohol consumed. Of women who were not “addicted" to alcohol, education 
about the adverse effects of alcohol was found to be sufficient to change their drinking 
habits. On the other hand, alcoholic women, defined as those who drank more than 125 g 
of pure alcohol per day, required intensive counseling in order to reduce their drinking. 
Information regarding the effects of how an alcoholic environment endangers the baby's 
development had the strongest effect on influencing drinking habits. The supportive 
environment was also an important component. The patients were provided free access to 
a social worker, a psychiatrist, and the Department of Social Welfare to aid in improving 
their domestic situation. 
Another program, organized by Little et al., provided public education, a 24 hour 
crisis information line, adult treatment services, adult education, and assessment of the 
infants (Little et al. 1984). About 50% of the women enrolled in this program were able 
to abstain or significantly reduce their alcohol consumption prior to the third trimester 
with those who decreased their alcohol intake delivering healthier infants. The estimated 
cost of the project was approximately one million dollars which is equivalent to the cost 
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of providing care for one severely retarded child affected by FAS for a lifetime. Thus, 
the cost is minimal relative to the amount that might be spent without the program. 
Although it would be ideal to give supportive counseling to every gravid woman, it 
simply is not feasible due to time and economic constraints. Each of the above described 
counseling programs met with the women a couple of times per month which requires a 
great deal of effort by the counselors. It would be impossible to do this with every 
woman who is pregnant. The evidence is convincing that even alcoholic women have the 
potential to stop or decrease their drinking habits before the third trimester. Evidence 
from laboratory animals and from women who have stopped drinking, shows that a 
significant amount of neurological damage can be done in the third trimester and damage 
done prior to the third trimester may be reduced if drinking is stopped or at least curtailed. 
Our study, shows that certain measurements are significantly different in “at risk” women 
late in the second trimester of pregnancy. Thus, if the women who have a combination of 
a positive T-ACE questionnaire and ultrasonographic measurements suspicious for FAS 
associated developmental anomalies could be placed in an intensive counseling group, 
their children could be helped prior to birth. In addition, early detection by the 
obstetrician would alert the pediatrician to a potential problem. Thus, the child could be 
watched closely for developmental delay and be put into an appropriate educational 
program early in life. It has been shown that children with FAS do better with early 
educational intervention (Streissguth et al. 1991). 
The prospect that a large percentage of pregnant alcoholic mothers are able to 
eliminate or decrease their intake of alcohol makes the possibility of prenatal diagnosis of 
FAS more important. Currently, prenatal diagnosis of abnormalities is aided by 
ultrasonography, maternal serum markers, and chromosomal anomalies. Unfortunately 
the anomalies detected by these methods, such as Down’s syndrome, spina bifida, or 
structural organ defects, are not preventable or alterable in utero. On the other hand, 
intensive counseling of the selected mothers determined by a prenatal diagnostic test for 
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FAS may lead to mitigation or even prevention of the severe neurological impairment 
seen in FAS. In this study, the possibility of prenatal detection of FAS is investigated 
through the combination of an assessment aimed at discovering potential alcoholic 
mothers, the T-ACE questionnaire, and a means of studying the development of facial 
features and intracranial growth, the ultrasound examination. The results thus far are 
encouraging as both craniofacial and intracranial measurements reach statistical 
significance at 24-28 weeks, although we need about 2600 patients for the results to be 
definitive. In conclusion, this study suggests that the prenatal detection of FAS is 
possible in the second trimester with the combination of the T-ACE questionnaire and 
prenatal ultrasonographic examination; thus, providing an avenue for secondary 
prevention of FAS. 
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TABLE I: Abnormal findings in infants born with FAS 
Skeletal 
Hypoplastic toenails 
Shortened fingers 
Radioulnar synostosis 
Flexion contractures of the elbow 
Camptodactyly of the fingers 
Clinodactyly of the toes 
Decreased flexion of the metacarpophalangeal joints 
Hip dislocation 
Spinal stenosis 
Scoliosis 
Pectus excavatum 
Pectus carinatum 
Polydactyly 
Cardiac 
Atrial septal defect 
Ventricular septal defect 
Hypoplasia of pulmonary arteries 
Neurological 
Microcephaly 
Cerebellar dysgenesis 
Corpus callosum agenesis 
Neural tube defects- anencephaly, myelomeningocele 
Renal 
Renal hypoplasia 
pyelonephritis 
Painless hematuria 
Immunological 
Increased susceptibility to bacterial infection_ 
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TABLE II: Accuracy of tests available for alcoholism screening 
Sensitivity Specificity Positive predictive 
value 
Negative predictive 
value 
MAST 36% 96% 29% 97% 
CAGE 38% 92% 18% 97% 
T-ACE 69% 89% 23% 98% 
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TABLE III: FAS characteristics: Which are detectable by ultrasonography? 
Characteristic Definitely detectable Possiblv detectable bv Undetectable bv 
bv ultrasonography* ultrasonography* ultrasonography 
Growth retardation 
Prenatal X 
Postnatal N/A N/A N/A 
Facial dysmorphology 
Microcephaly 
Short palpebral fissures 
Epicanthal folds 
Midfacial hypoplasia 
Short nose 
Indistinct philtrum 
Micrognathia 
Thin upper lip 
Central nervous system 
Small brain size x-T-IS,C-IS 
Tremulousness 
Fine motor dysfunction x-TCD 
Hyperactivity 
Poor attention span 
Mental retardation 
x 
x 
X 
X 
x- HC 
x-OOD, IOD 
x 
x-MFT 
x-MOMUD,MOMD 
x 
x-MOMD 
x 
* Abbreviations refer to measurements we hope will determine the corresponding characteristic. 
See text for abbreviations and explanations. The characteristics should be detectable at all three 
ultrasound periods in this study. 
HC: head circumference 
OOD: outer-orbital diameter 
IOD: inner-orbital diameter 
MFT: outer-orbital to mid-upper lip distance 
MOMUD: mid-orbital to mid-upper lip distance 
MOMD: mid-orbital to mandible distance 
T-IS: thalamus to inner-table of the skull distance 
C-IS: cavum septum pellucidum to inner-table of the skull distance 
TCD: transcerebellar diameter 
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TABLE IV: Characteristics of women in study 
WOMEN’S CENTER 
(N=73) 
YALE U/S UNIT 
(N= 62) 
GESSLER CLINIC 
(N= 130) 
T-ACE 
positive 
(N=26) 
T-ACE 
negative 
(N=47) 
T-ACE 
positive 
(N=l 1) 
T-ACE 
negative 
(N=51) 
T-ACE 
positive 
(N=57) 
T-ACE 
negative 
(n=73) 
AGE(YR)± SD 25.9 ± 4.7 23.5 ±4.3 27.8 ± 5.2 26.9 ± 6.9 27 ± 5.9 26.8 ± 4.5 
GRAVIDITY ± SD 3.4 ± 2.2 3.4 ±2.2 5.0 ± 2.4 3.3 ±2.1 2.2 ± 1.2 2.4 ± 1.2 
PARITY ± SD 1.2 ± 1.2 1.4 ± 1.2 2.4 ± 2.4 1.2 ± 1.2 0.8 ± 1.0 1.1 ±0.9 
% CAUCASIAN 42 38 54 82 96 97 
% BLACK 50 49 46 8 2 1.5 
% OTHER 8 13 0 10 2 1.5 
% POS CIGARETTES 54 38 36 8 N/A N/A 
% POS ILLICIT DRUGS 38 6 46 0 N/A N/A 
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TABLE V: Comparison of T-ACE positive and T-ACE negative (16-19 weeks) 
16-19 WEEKS (N=51) 
STANDARD T-ACE T-ACE Z-VALUE* 
MEANS POSITIVE NEGATIVE 
N=19 N=32 
GA 
MEAN ± SD 
(mm) 
17.7 ± .9 
MEAN ± SD 
(mm) 
17.9 ±.8 
BPD 40.2 ±4.0 41.3 ±3.9 
OFD 49.3 ±4.8 50.1 ±9.3 
HC 142.5 (Hadlock 
et al. 1983) 
139.7 ± 11.7 148.1 ± 11.7 1.37# 
OOD 27.4 (Mayden et 
al. 1982) 
29.0 ±2.6 29.8 ± 3.2 1.01 
IOD 10.7 (Mayden et 
al. 1982) 
10.9 ± 1.7 11.6 ± 1.4 1.21 
MOMD 20.6 ± 2.0 19.8 ±3.3 0.53 
MOMUD 9.8 ± 1.3 10.2 ±2.0 1.57 
MFT 18.8 ±2.8 19.3 ±2.8 0.15 
TCD 17.5 (Goldstein 
et al. 1987) 
18.2 ± 1.5 18.0 ± 1.4 0.15 
C-IS 20.1 ±2.2 20.3 ± 2.2 0.10 
T-IS 34.5 ± 3.3 34.4 ±3.1 0.12 
*As determined by Mann-Whitney rank sum test 
#p<.05 
GA: gestational age 
BPD: biparietal diameter 
OFD: occipito-frontal diameter 
HC: head circumference 
OOD: outer-orbital diameter 
lOD: inner-orbital diameter 
MOMD: mid-orbital to mandible distance 
MOMUD: mid-orbital to mid-upper lip distance 
MFT: outer-orbital to mid-upper lip distance 
TCD: transcerebellar diameter 
C-IS: cavum septum pellucidum to inner-table of the skull distance 
T-IS: thalamus to inner-table of the skull distance 
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TABLE VI: Comparison of T-ACE positive and T-ACE negative (24-28 weeks) 
24-28 WEEKS (N=53) 
STANDARD 
MEANS 
T-ACE 
POSITIVE 
N= 21 
T-ACE 
NEGATIVE 
N= 32 
Z-VALU 
GA 
MEAN ± SD 
(mm) 
25.7 ± 1.1 
MEAN 1 SD 
(mm) 
26.5 11.2 
BPD 64.714.1 66.2 14.2 
OFD 82.217.1 85.6 16.2 
HC 242.5 (Hadlock 
et al. 1983) 
231.2115.6 239.61 15.0 1.82 
OOD 44.2 (Mayden et 
al. 1982) 
44.013.8 44.5 1 3.3 0.04 
IOD 16.6 (Mayden et 
al. 1982) 
15.71 1.7 16.612.1 0.87 
MOMD 31.712.7 34.2 14.4 1.60 
MOMUD 17.01 1.7 19.214.5 0.96 
MFT 26.91 2.9 27.414.9 0.68 
TCD 28.5 (Goldstein 
et al. 1987) 
26.91 2.2 29.613.1 3.01# 
C-IS 29.815.8 32.3 1 3.9 1.41 
T-IS 49.018.3 54.014.3 2.19# 
*As determined by Mann-Whitney rank sum test 
#p<.05 
GA: gestational age 
BPD: biparietal diameter 
OFD: occipito-frontal diameter 
HC: head circumference 
OOD: outer-orbital diameter 
IOD: inner-orbital diameter 
MOMD: mid-orbital to mandible distance 
MOMUD: mid-orbital to mid-upper lip distance 
MFT: outer-orbital to mid-upper lip distance 
TCD: transcerebellar diameter 
C-IS: cavum septum pellucidum to inner-table of the skull distance 
T-IS: thalamus to inner-table of the skull distance 
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TABLE VII: Comparison of T-ACE positive and T-ACE negative (32-35 weeks) 
32-35 WEEKS (N=25) 
STANDARD 
MEANS 
T-ACE 
POSITIVE 
N=9 
T-ACE 
NEGATIVE 
N=16 
Z-VALUE* 
GA 
MEAN ± SD 
(mm) 
33.4 ± .90 
MEAN± SD 
(mm) 
33.4 ± 0.8 
BPD 83.7 ±4.2 82.9 ± 3.5 
OFD 106.3 ±5.1 104.9 ±5.3 
HC 396.2 (Hadlock 
et al. 1983) 
302.6 ± 16.4 297.4 ± 13.4 0.76 
OOD 53.4 (Mayden et 
al. 1982) 
53.2 ±3.0 53.9 ± 1.9 1.20 
IOD 19 (Mayden et 
al. 1982) 
20.6 ±2.9 20.0 ±3.1 0.35 
MOMD 41.8 ±3.8 44.5 ±3.1 1.19 
MOMUD 19.8 ±2.8 22.8 ± 3.0 1.41 
MFT 30.2 ± 5.4 34.4 ± 3.6 1.87 
TCD 39.6 (Goldstein 
et al. 1987) 
36.6 ±4.2 38.0 ±2.2 0.15 
C-IS 41.8 ±6.2 41.9 ±3.1 0.36 
T-IS 65.4 ± 3.8 65.6 ±4.9 0.05 
*As determined by Mann-Whitney rank sum test 
GA: gestational age 
BPD: biparietal diameter 
OFD: occipito-frontal diameter 
HC: head circumference 
OOD: outer-orbital diameter 
IOD: inner-orbital diameter 
MOMD: mid-orbital to mandible distance 
MOMUD: mid-orbital to mid-upper lip distance 
MET: outer-orbital to mid-upper lip distance 
TCD: transcerebellar diameter 
C-IS: cavum septum pellucidum to inner-table of the skull distance 
T-IS: thalamus to inner-table of the skull distance 
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Figure I: Characteristic facial features in fetal alcohol syndrome (Streissguth and LaDue 
1987) 
microcephaly 
short palpebral 
fissures 
flat midface 
indistinct philtrum 
thin upper lip 
epicanthal folds 
low 
nasal bridge 
minor 
ear anomalies 
short nose 
micrognathia 
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Figure II: Depiction of ultrasonographic measurements 
1. Biparietal diameter (BPD) 5. Cerebellum to inner table of skull (C-IS) 
2. Occipito-frontal diameter (OFD) 6. Outer orbital distance (OOD) 
3. Transcerebellar diameter (TCD) 7. Inner orbital distance (IOD) 
4. Thalamus to inner table of skull (T-IS) 8. Mid-orbital to mandible distance (MOMD) 
9. Mid-orbital to mid-upper lip distance(MOMUD) 
10. Outer orbital to mid-upper lip distance (MFT) 
(Viscarello et al. 1991) 
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APPENDIX I 
NAME. DATE 
UNIT # RACE DOB 
LMP GA AGE 
G P sAB tAB ect 
ALCOHOL 
1. How many drinks does it take to get you "high"? 
2. Are you annoyed when friends suggest that you 
should alter your drinking habits? 
3. Have you yourself felt the need to cut down on your 
drinking? 
4. Have you ever had a drink to "cure" a hangover or 
to get started in the morning? 
5. How many drinks can you hold? 
T-ACE TOTAL SCORE 
AMOUNT, FREQ, & COST OF DRUG/WK 
DRUG ROUTE Prnnrf<j T rim 1 T rim 2 1 Trim 3 
COCAINE 
HEROIN 
MARIJUANA 
METHADONE 
VALIUM 
OTHER 
TOBACCO 
Number' of years smoking 
Number of cigarettes per day while pregnant 
Number of cigarettes per day prior to pregnancy 
STD 
HIV 
Syphilis 
Hepatitis B Condyloma 
Chlamydia Herpes 
CC Trichomonas 
Other 
Yale Perinatal Chemical Dependence Center 
YPCDC Form 790-01 
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